Filing Details
- Accession Number:
- 0001213900-24-016026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-22 13:38:46
- Reporting Period:
- 2024-02-21
- Accepted Time:
- 2024-02-22 13:38:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1728328 | Inmed Pharmaceuticals Inc. | INM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1818252 | Andrew Hull | C/O Inmed Pharmaceuticals Inc. 310-815 West Hastings St. Vancouver A1 V6C1B4 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-21 | 37,500 | $0.39 | 38,258 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
